Back
Primis Financial Corp. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
56
FRST
Primis Financial Corp.
Last Price:
$13.36
Seasonality Move:
-0.62%
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$36.97
Seasonality Move:
12.55%
Buy
56
Primis Financial Corp. (FRST)
is a Buy
Is Primis Financial Corp. a Buy, Sell or Hold?
-
The current Primis Financial Corp. [FRST] share price is $13.36. The Score for FRST is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
FRST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FRST Stock Price Chart
What is Primis Financial Corp.'s stock price today?
-
The Primis Financial Corp. share price today is $13.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FRST is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $36.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FRST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 55.99 | Buy |
| Chaikin Money Flow: | 52182 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.81 - 13.29) | Buy |
| Bollinger Bands (100): | (11.86 - 13.92) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 14566902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.41 - 38.59) | Sell |
| Bollinger Bands (100): | (39.84 - 55.48) | Sell |
FRST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.24 | Buy |
| 20-day SMA: | 13 | Buy |
| 50-day SMA: | 13.44 | Sell |
| 200-day SMA: | 11.88 | Buy |
| 8-day EMA: | 13.22 | Buy |
| 20-day EMA: | 13.16 | Buy |
| 50-day EMA: | 13.17 | Buy |
| 200-day EMA: | 12.16 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.4 | Buy |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 44.19 | Sell |
| 200-day SMA: | 53.09 | Sell |
| 8-day EMA: | 36.61 | Buy |
| 20-day EMA: | 37.8 | Sell |
| 50-day EMA: | 42.18 | Sell |
| 200-day EMA: | 54.43 | Sell |
Primis Financial Corp. Earnings Growth & FRST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $0.43 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.
Primis Financial Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||